133 related articles for article (PubMed ID: 16935599)
1. Esterified estrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women.
Khurana RN; LaBree LD; Scott G; Smith RE; Yiu SC
Am J Ophthalmol; 2006 Sep; 142(3):494-5. PubMed ID: 16935599
[TBL] [Abstract][Full Text] [Related]
2. Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women.
Scott G; Yiu SC; Wasilewski D; Song J; Smith RE
Am J Ophthalmol; 2005 Jun; 139(6):1109-10. PubMed ID: 15953447
[TBL] [Abstract][Full Text] [Related]
3. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women.
Hickok LR; Toomey C; Speroff L
Obstet Gynecol; 1993 Dec; 82(6):919-24. PubMed ID: 8233265
[TBL] [Abstract][Full Text] [Related]
4. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women.
Warnock JK; Swanson SG; Borel RW; Zipfel LM; Brennan JJ;
Menopause; 2005; 12(4):374-84. PubMed ID: 16037752
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study.
Liu J; Allgood A; Derogatis LR; Swanson S; O'Mahony M; Nedoss B; Soper H; Zbella E; Prokofieva SV; Zipfel L; Guo CY
Fertil Steril; 2011 Jan; 95(1):366-8. PubMed ID: 20850731
[TBL] [Abstract][Full Text] [Related]
6. Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States.
Phillips E; Bauman C
Clin Ther; 1997; 19(5):1070-84. PubMed ID: 9385494
[TBL] [Abstract][Full Text] [Related]
7. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms.
Adamson DL; Webb CM; Collins P
Menopause; 2001; 8(4):233-8. PubMed ID: 11449079
[TBL] [Abstract][Full Text] [Related]
8. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
[TBL] [Abstract][Full Text] [Related]
9. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.
Penteado SR; Fonseca AM; Bagnoli VR; Abdo CH; Júnior JM; Baracat EC
Climacteric; 2008 Feb; 11(1):17-25. PubMed ID: 18202961
[TBL] [Abstract][Full Text] [Related]
10. Estratest and Estratest HS (esterified estrogens and methyltestosterone) therapy: a summary of safety surveillance data, January 1989 to August 2002.
Phillips EH; Ryan S; Ferrari R; Green C
Clin Ther; 2003 Dec; 25(12):3027-43. PubMed ID: 14749144
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on ocular function in postmenopause.
Affinito P; Di Spiezio Sardo A; Di Carlo C; Sammartino A; Tommaselli GA; Bifulco G; Loffredo A; Loffredo M; Nappi C
Menopause; 2003; 10(5):482-7. PubMed ID: 14501611
[TBL] [Abstract][Full Text] [Related]
12. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
Lee EW; Hariprasad SM; Mieler WF; Newman TL; Apte RS
Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
[TBL] [Abstract][Full Text] [Related]
13. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
14. Association between serum estradiol level and intraocular pressure in postmenopausal women.
Kang BM; Koo YH; Lee SR; Kim SH; Chae HD; Kim CH
J Reprod Med; 2009 Aug; 54(8):483-7. PubMed ID: 19769193
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
Dobs AS; Nguyen T; Pace C; Roberts CP
J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
[TBL] [Abstract][Full Text] [Related]
18. Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
Erdurmus M; Cohen EJ; Yildiz EH; Hammersmith KM; Laibson PR; Varssano D; Rapuano CJ
Cornea; 2009 Aug; 28(7):759-64. PubMed ID: 19574912
[TBL] [Abstract][Full Text] [Related]
19. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
Ishibashi S; Hirose N; Tawara A; Kubota T
J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
Lobo RA; Rosen RC; Yang HM; Block B; Van Der Hoop RG
Fertil Steril; 2003 Jun; 79(6):1341-52. PubMed ID: 12798881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
